SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-20-009835
Filing Date
2020-04-22
Accepted
2020-04-22 16:37:05
Documents
74
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea120894-6k_chinasxt.htm 6-K 165403
2 CHINA SXT PHARMACEUTICALS, INC. UNAUDITED FINANCIAL RESULTS FOR THE SIX MONTHS E ea120894ex99-1_chinasxt.htm EX-99.1 262231
  Complete submission text file 0001213900-20-009835.txt   2980815

Data Files

Seq Description Document Type Size
3 XBRL INSTANCE FILE sxtc-20190930.xml EX-101.INS 455766
4 XBRL SCHEMA FILE sxtc-20190930.xsd EX-101.SCH 46993
5 XBRL CALCULATION FILE sxtc-20190930_cal.xml EX-101.CAL 61865
6 XBRL DEFINITION FILE sxtc-20190930_def.xml EX-101.DEF 124564
7 XBRL LABEL FILE sxtc-20190930_lab.xml EX-101.LAB 264956
8 XBRL PRESENTATION FILE sxtc-20190930_pre.xml EX-101.PRE 228971
Mailing Address 178 TAIDONG ROAD NORTH TAIZHOU F4 225300
Business Address 178 TAIDONG ROAD NORTH TAIZHOU F4 225300 8652386298290
China SXT Pharmaceuticals, Inc. (Filer) CIK: 0001723980 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 0331
Type: 6-K | Act: 34 | File No.: 001-38773 | Film No.: 20808289
SIC: 2834 Pharmaceutical Preparations